Výsledky vyhledávání

Will happiness-trainings make us happier?

Autor: Ad Bergsma, I. Buijt, Ruut Veenhoven

Publikováno v: Frontiers in Psychology, Vol 11 (2020)
Frontiers in Psychology, 11:1953. Frontiers Media S.A.
Frontiers in Psychology

Most people want to be happy and many look out for opportunities to achieve a more satisfying life. Following a happiness training is an option, but the effectiveness of such training is being questioned. In this research synthesis we assessed: (1) w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::219412471f7b54830b5d821c52c8c6a0
https://pure.eur.nl/en/publications/83b2526c-465a-4ef1-a1ff-3f627201af0b

Zobrazit plný text záznamu

Self-reported quality of life in elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy

Autor: Monique Steijaert, Jeanette K. Doorduijn, Pieter Sonneveld, Carin A. Uyl-de Groot, I. Buijt, Bronno van der Holt

Publikováno v: European Journal of Haematology, 75(2), 116-123. Wiley-Blackwell Publishing Ltd

We studied the impact of CHOP chemotherapy on the quality of life (QoL) of elderly patients with aggressive non-Hodgkin's lymphoma (NHL). 132 patients aged 65 or older, who participated in a randomized, multicenter trial, completed QoL questionnaires

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d7e9040629141f2f00f938117ab9740
https://doi.org/10.1111/j.1600-0609.2005.00438.x

Zobrazit plný text záznamu

A cost-utility analysis comparing intensive chemotherapy alone to intensive chemotherapy followed by myeloablative chemotherapy with autologous stem-cell rescue in newly diagnosed patients with stage II/III multiple myeloma

Autor: C.M. Segeren, B. van der Holt, C.A. Uyl-de Groot, M van Agthoven, I. Buijt, Pieter Sonneveld, Henk M. Lokhorst

Publikováno v: European Journal of Cancer. 40:1159-1169

A prospective randomised phase III study in patients < or =65 years old with previously untreated multiple myeloma (MM), intensive chemotherapy followed by myeloablative chemotherapy and autologous stem-cell rescue was compared with intensive chemoth

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fa40847e4e76303836aa965ff6697f61
https://doi.org/10.1016/j.ejca.2004.01.019

Zobrazit plný text záznamu

Autor: M VANAGTHOVEN, C SEGEREN, I BUIJT, C UYLDEGROOT, B VANDERHOLT, H LOKHORST, P SONNEVELD

Publikováno v: European Journal of Cancer. 40:1159-1169

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::62090b0caf6f041bffdcdcbe018624ce
https://doi.org/10.1016/s0959-8049(04)00128-5

Zobrazit plný text záznamu

CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma

Autor: Andries H. Mulder, M. R. Schaafsma, Pieter Sonneveld, J.K. Doorduijn, L. F. Verdonck, M van Agthoven, Monique Steijaert, C.A. Uyl-de Groot, K. G. van der Hem, Gert J. Ossenkoppele, Gregor Verhoef, G. W. van Imhoff, B. van der Holt, M. H. J. Van Oers, M. H. H. Kramer, I. Buijt

Publikováno v: Journal of Clinical Oncology, 21(16), 3041-3050. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 21(16), 3041-3050. American Society of Clinical Oncology
Journal of clinical oncology, 21(16), 3041-3050. American Society of Clinical Oncology

Purpose: To investigate whether the relative dose-intensity of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy could be improved by prophylactic administration of granulocyte colony-stimulating factor (G-CSF) in elderly

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76fb458dca7602bcb57de233e314bc01
https://doi.org/10.1200/jco.2003.01.076

Zobrazit plný text záznamu

Costs of intensive treatment and follow-up of patients with multiple myeloma

Autor: C. A. Uyl-De Groot, Gert J. Ossenkoppele, I. Buijt, Peter C. Huijgens

Publikováno v: Anti-Cancer Drugs. 9:889-898

In a retrospective study, we calculated the treatment and follow-up costs of patients with newly diagnosed multiple myeloma. The total treatment programme consisted of eight phases: VAD or VAMP chemotherapy, follow-up I, high-dose melphalan followed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebee77b60542e84d0d69d89121d9a95a
https://doi.org/10.1097/00001813-199811000-00008

Zobrazit plný text záznamu

Autor: M, van Agthoven, C M, Segeren, I, Buijt, C A, Uyl-de Groot, B, van der Holt, H M, Lokhorst, P, Sonneveld

Publikováno v: European journal of cancer (Oxford, England : 1990). 40(8)

A prospective randomised phase III study in patientsor =65 years old with previously untreated multiple myeloma (MM), intensive chemotherapy followed by myeloablative chemotherapy and autologous stem-cell rescue was compared with intensive chemothera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ef7f8544e276c68879c205826e343e08
https://pubmed.ncbi.nlm.nih.gov/15110879

Zobrazit plný text záznamu

Stem cell transplantations in patients with malignant lymphoma: costs in a Dutch university hospital in the period 1984-1995

Autor: Gert J. Ossenkoppele, C.A. Uyl-de Groot, Peter C. Huijgens, I. Buijt

Publikováno v: Journal of Hematotherapy & Stem Cell Research, 619-625. Mary Ann Liebert Inc.
ISSUE=8;STARTPAGE=619;ENDPAGE=625;ISSN=1525-8165;TITLE=Journal of Hematotherapy & Stem Cell Research

In the past 15 years, perspectives on treatment of patients with relapsed non-Hodgkin's lymphoma have changed. This has had important consequences for the costs of treatment. We conducted a retrospective study comparing the costs of four different tr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc892b94c7156da0de189ccdc4795410
https://pubmed.ncbi.nlm.nih.gov/10645769

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání